C1QC encodes the C-chain subunit of the complement component C1, the initiating complex of the classical complement pathway. The C1 complex consists of one C1q subunit (made of C1QA, C1QB, and C1QC chains) and two C1r and C1s protease subunits. C1QC is essential for immune complex recognition and activation of the complement cascade, playing a critical role in both peripheral immunity and neuroinflammation within the central nervous system. [1]
| C1QC |
|---|
The C1QC gene encodes a component of the complement system, part of the innate immune system involved in inflammation and immune response.
The C1QC gene encodes the C chain of the C1q protein, which is the recognition component of the classical complement pathway. C1q is a hexameric molecule composed of 6 A chains, 6 B chains, and 6 C chains (C1QA, C1QB, C1QC). Each chain contributes to the overall structure and function of the C1q complex.
C1q serves as a pattern recognition receptor that binds to:
Upon binding, C1q triggers the activation of the classical complement cascade, leading to opsonization, inflammation, and cell lysis through the formation of the membrane attack complex (MAC).
C1q plays a significant role in neuroinflammation and has been implicated in several neurodegenerative conditions:
C1QC is expressed in various tissues, with high expression in:
In the brain, C1q expression increases with age, and this age-related increase is particularly notable in regions vulnerable to neurodegenerative processes.
The study of C1Qc has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.